	Effectiveness and safety of trastuzumab-anns compared to reference trastuzumab among patients with HER2-positive breast cancer: A non-inferiority study. J Oncol Pharm Pract Shin P, Niu F, Nguyen DD, Ho SL, Shah N, Durna L, Hui RL. PMID: 41891192 [PubMed - as supplied by publisher]
	The preventive effects of plantago major, mallow and Honey on radiation-induced dermatitis in patients with breast cancer: A double-blind clinical trial. J Oncol Pharm Pract Asadi A, Javadinia SA, NeamatShahi M, Hamedi S, NematShahi M, Ghorat F, Alhouei B, Doaei S. PMID: 41891190 [PubMed - as supplied by publisher]
	Assessing mental health, cognitive function and quality of life of breast cancer patients: exploring associations with gut microbiota in an observational and preliminary study. Front Psychol Calafate C, Alpuim Costa D, Campos T, Ribeiro PC, Martinho F, Freitas C, Botelho de Sousa C, Negreiros I, Canastra A, Borralho P, Pereira AG, Marçal C, Ribeiro R, Sousa JG, Dinis C, Chaleira R, Calha R, Rocha JC, Calhau C, Moreira-Rosário A, Faria A. PMID: 41890921 [PubMed]
	Leucogen-induced pemphigus foliaceus: the first case report. Front Immunol Gui K, Liang J, Gao A, Luo Y, Tian X. PMID: 41890748 [PubMed - indexed for MEDLINE]
	Risk factors for dyseugia during chemotherapy in breast cancer women: A cohort STROBE-guided. J Clin Exp Dent Nóbrega Malta CE, Fontes Borges MM, Aragão Matos Carlos AC, Crispim AA, Barbosa JV, Silva Marques Araújo AB, Gonzaga Silva LF, Bastos de Moura JF, de Barros Silva PG. PMID: 41890678 [PubMed]
	Spatiotemporal Mapping of Tumor Microenvironment Remodeling During Fiber-Optic Photothermal Therapy: A Multiparametric MRI Study in 4T1 Breast Cancer Xenografts. Chem Biomed Imaging Xu B, Cheng Z, Feng Y, Li Z, Jin F, Ran Y, Cai X. PMID: 41889464 [PubMed]
	Integrative Raman Spectroscopy and Multi-Omics Analysis of Lipid and Matrix Protein Heterogeneity in Triple-Negative Breast Cancer. Chem Biomed Imaging Sheikh E, Salim K, Guttula PK, Burk DH, Belgodere JA, Beavers WN, Stephanes NM, Agrawal K, Dubansky BH, Donnarumma F, Burow ME, Martin EC, Gartia MR. PMID: 41889458 [PubMed]
	Challenges in employing overall survival as a primary outcome in ovarian cancer studies: insights from PARP inhibitor trials. Front Oncol Siegler Y, Matanes E. PMID: 41889409 [PubMed]
	The role and research progress of FGF21 in breast cancer: a review. Front Oncol Chen J, Chang C, Yang X. PMID: 41889408 [PubMed]
	Development and validation of an interpretable ensemble model for predicting androgen receptor status in triple-negative breast cancer: a multi-center study. Front Oncol Ruan M, Cao L, Liu Y, Shan Y, Li Z, Shao C, Xu W. PMID: 41889401 [PubMed]
	A randomized controlled trial to evaluate an adapted community health worker-delivered breast and cervical cancer screening education and navigation intervention for underserved Latina adults. Front Oncol Savas LS, Heredia NI, Huyan Y, Coan S, Martin S, Mantey DS, Adlparvar EM, Yao KG, Alaniz A, Figueroa E, Fernandez ME. PMID: 41889398 [PubMed]
	Distinguishing granulomatous lobular mastitis from breast cancer using a clinical-radiomics nomogram to improve diagnostic accuracy. Front Oncol Wang Y, Zuo X, Zhai J, Gao X, Chen Z, Li X, Pei W, Shi X. PMID: 41889397 [PubMed]
	Exosome crown proteins are promising markers for liquid biopsy of breast cancer. Front Oncol Tamkovich S, Shefer A, Kalichkin A, Chernyshova A. PMID: 41889394 [PubMed]
	Dual HER2/ERÎ± Inhibitors for Breast and Ovarian Cancer: An Integrated Computational Study on 1,2,4-Oxadiazole Derivatives. Chem Biodivers Khan MA, Jabbar A, Sidra LR, Naseem F, Khan AA, Mutahir S, Al-Saeedi SI, Alzahrani E, Zhou G. PMID: 41889096 [PubMed - indexed for MEDLINE]
	Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: a clinicopathological diagnostic study and molecular features. Diagn Pathol Yu M, Jiang M, Zhang X, Chen H, Ye X. PMID: 41888927 [PubMed - as supplied by publisher]
	Interactive symptom monitoring and coaching to optimise toxicity management of chemo(immune)therapy in early stage breast cancer: study protocol of the multicentre randomised controlled eChemoCoach trial. BMC Cancer Verduin RJT, van den Hurk CJG, van Maurik IS, Nota NM, van Leeuwen-Stok AE, Komen MMC, Jager A, Drossaert CHC, Siesling S, Hendriks MP. PMID: 41888754 [PubMed - as supplied by publisher]
	Insights Into 'Living Flat': A Qualitative Study of Patients Who Have Mastectomy Without Reconstruction. Psychooncology Lyons L, Martin C, Wyld L, King N, Brunsden S, Morgan J. PMID: 41888602 [PubMed - indexed for MEDLINE]
	Return to work and cancer survivorship needs of breast cancer survivors: an observational prospective single-cohort study in Italy. Sci Rep Paltrinieri S, Braglia L, Bravi F, Fugazzaro S, Costi S. PMID: 41888269 [PubMed - as supplied by publisher]
	The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study. Sci Rep Oruç A, Delikta, Uyar GC, , Tünbekici S, Arslan Kapuci A, Ulukal Karanc, Kemik F, Y, Ate, , Aksoy S, Çakar B, Özdemir N, Öztürk B, Selçukbiricik F, Koçak MZ, Karakurt Ery, Araz M, Artaç M. PMID: 41888201 [PubMed - as supplied by publisher]
	Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial. Nat Commun Porter RL, Zhou Y, Eskndir N, Hayes M, Polak M, Lee EK, Krasner C, Campos S, Wright AA, Liu JF, Stover EH, Sawyer H, Xiong N, Pfaff KL, Rodig SJ, Tayob N, Zweizig S, John V, Veneris J, Matulonis UA, Konstantinopoulos PA. PMID: 41888141 [PubMed - as supplied by publisher]

Articles 1 - 20 / 326456

Page 1 of 16323



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy